000 | 01320 a2200361 4500 | ||
---|---|---|---|
005 | 20250513212607.0 | ||
264 | 0 | _c20000713 | |
008 | 200007s 0 0 eng d | ||
022 | _a1084-9785 | ||
024 | 7 |
_a10.1089/cbr.1999.14.153 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBarbet, J | |
245 | 0 | 0 |
_aPretargeting with the affinity enhancement system for radioimmunotherapy. _h[electronic resource] |
260 |
_bCancer biotherapy & radiopharmaceuticals _cJun 1999 |
||
300 |
_a153-66 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Bispecific _xpharmacokinetics |
650 | 0 | 4 |
_aCarcinoma, Medullary _xdiagnostic imaging |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Neoplasms _xdiagnostic imaging |
650 | 0 | 4 |
_aNeoplasms _xdiagnostic imaging |
650 | 0 | 4 | _aRadioimmunodetection |
650 | 0 | 4 |
_aRadioimmunotherapy _xmethods |
650 | 0 | 4 |
_aThyroid Neoplasms _xdiagnostic imaging |
700 | 1 | _aKraeber-Bodéré, F | |
700 | 1 | _aVuillez, J P | |
700 | 1 | _aGautherot, E | |
700 | 1 | _aRouvier, E | |
700 | 1 | _aChatal, J F | |
773 | 0 |
_tCancer biotherapy & radiopharmaceuticals _gvol. 14 _gno. 3 _gp. 153-66 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/cbr.1999.14.153 _zAvailable from publisher's website |
999 |
_c10801400 _d10801400 |